Expression data from HCT116 cells

ABSTRACT: Advanced colon cancer is characterized by drug resistance and a poor prognosis. In these patients tumor-propagating cells appear to be largely resistant against various targeted drugs including ErbB-inhibitors. The cell surface antigen prominin-1 (CD133) has recently been identified as a potential marker of colon cancer stem cells. The purpose of this study was to define mRNA expression patterns in CD133+ and CD133- HCT116 cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE38049 | GEO | 2012/05/22

SECONDARY ACCESSION(S): PRJNA167129

REPOSITORIES: GEO